Over the last decade, several studies have investigated the role of glucose-lowering drugs in cardiovascular outcomes, especially glucagon-like peptide-1 receptor agonists (GLP1-RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) which have demonstrated substantial improvements in major cardiovascular events, kidney function outcomes, and hospitalizations [3]
These injections can give a boost to any weight loss regimen when combined with a healthy diet and exercise program, and can be taken along with GLP-1 medications to augment their effectiveness
Probiotics for nausea and bloating Nausea is the side effect most semaglutide users fear, and it is the one with the weakest direct probiotic evidence
Experience the Biostation Difference At the biostation, we are committed to providing you with the highest quality care and personalized attention every step of the way
Ongoing investigation continues to examine how these peptides and weight loss pathways interact with body composition, lean mass retention, metabolic markers, and long-term physiological adaptation
Patients in the 7.5 mg group received 2.5 mg for the initial 4 weeks, followed by 5.0 mg for the next 4 weeks
